z-logo
Premium
Randomized controlled multicentre study comparing short dental implants (6 mm) versus longer dental implants (11–15 mm) in combination with sinus floor elevation procedures: 5‐Year data
Author(s) -
Thoma Daniel S.,
Haas Robert,
SporniakTutak Katarzyna,
Garcia Abel,
Taylor Thomas D.,
Hämmerle Christoph H. F.
Publication year - 2018
Publication title -
journal of clinical periodontology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.456
H-Index - 151
eISSN - 1600-051X
pISSN - 0303-6979
DOI - 10.1111/jcpe.13025
Subject(s) - medicine , dentistry , implant , maxillary sinus , survival rate , bone grafting , maxilla , implant failure , dental implant , osseointegration , surgery
Aim To compare the implant survival rate between short dental implants and standard length implants placed in combination with bone grafting at 5 years of loading. Methods This multicentre study enrolled 101 patients (137 implants) with a posterior maxillary bone height of 5–7 mm. Patients randomly received either short implants (6 mm; GS ) or long implants (11–15 mm) with sinus grafting ( GG ). Six months later, implants were loaded with single crowns and patients re‐examined at 1, 3 and 5 years of loading. Outcomes included: implant survival, marginal bone levels ( MBL s), biological and technical parameters and patient‐reported outcome measures ( OHIP ‐49 = Oral Health Impact Profile). Statistical analysis was performed using a non‐parametric approach. Results At 5 years, 90 patients (124 implants; GS : 60; GG : 64) were re‐examined (drop‐out rate 10%). Patient‐level implant survival rates were 98.5% ( GS ; 1 implant failure) and 100% ( GG ; p  = 0.49). Mean MBL s were 0.54 mm ± 0.87 ( GS ) and 0.46 mm ± 1.00 ( GG ; p  = 0.34). Biological and technical parameters were not significantly different ( p  > 0.05). Median overall OHIP ‐49 scores improved significantly up to 5 years in both groups ( GS : p  = 0.03; GG : p  = 0.00; intergroup comparison p  = 0.11). Conclusions Both treatment modalities were suitable for implant therapy in the atrophied posterior maxilla revealing no differences in terms of survival rates, marginal bone levels (changes), patient‐reported outcomes and technical/biological complications.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom